Specify a stock or a cryptocurrency in the search bar to get a summary
Divi's Laboratories Limited
DIVISLABDivi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India. Address: Divi Towers, Hyderabad, India, 500032
Analytics
WallStreet Target Price
413 937.41 INRP/E ratio
87.2109Dividend Yield
0.55 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures DIVISLAB
Dividend Analytics DIVISLAB
Dividend growth over 5 years
200 %Continuous growth
–Payout Ratio 5 years average
32 %Dividend History DIVISLAB
Stock Valuation DIVISLAB
Financials DIVISLAB
Results | 2019 | Dynamics |